{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:23:53Z","timestamp":1783124633396,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","award":["III L 5\\u2013519\/03\/03.001 (0015"],"award-info":[{"award-number":["III L 5\\u2013519\/03\/03.001 (0015"]}],"id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018992","name":"Fonds der Chemischen Industrie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01KD2206G"],"award-info":[{"award-number":["01KD2206G"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116776","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:09:49Z","timestamp":1777576189000},"page":"116776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy"],"prefix":"10.1016","volume":"241","author":[{"given":"Melis","family":"Onay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalbert F.","family":"de Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Kalinauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-549X","authenticated-orcid":false,"given":"Ingeborg","family":"Tinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1777-2359","authenticated-orcid":false,"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0131-3669","authenticated-orcid":false,"given":"Albrecht","family":"Piiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-1022","authenticated-orcid":false,"given":"Franz","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116776_bib1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3390\/curroncol30030246","article-title":"Anal cancer: the past, present and future","volume":"30","author":"Gondal","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"792","key":"10.1016\/j.ejca.2026.116776_bib3","first-page":"6","article-title":"Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001-2017","volume":"113","author":"Deshmukh","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2026.116776_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41571-025-01025-x","article-title":"Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer","volume":"22","author":"Rodel","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib5","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.07.035","article-title":"Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial","volume":"87","author":"Gunderson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2026.116776_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejca.2026.116776_bib9","first-page":"167","article-title":"Tumour hypoxia in driving genomic instability and tumour evolution","volume":"25","author":"Suvac","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2026.116776_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211036304","article-title":"Hypoxia and the tumor microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ejca.2026.116776_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2026.116776_bib12","article-title":"Prognostic implications of HIF-1alpha expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)","volume":"49","author":"Mohamed","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejca.2026.116776_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ejca.2026.116776_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.116776_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"Lin","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2026.116776_bib17","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gad.1848209","article-title":"Dicer1 functions as a haploinsufficient tumor suppressor","volume":"23","author":"Kumar","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.ejca.2026.116776_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1349-7006.2005.00015.x","article-title":"Reduced expression of Dicer associated with poor prognosis in lung cancer patients","volume":"96","author":"Karube","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2026.116776_bib19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2353\/ajpath.2006.060480","article-title":"Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma","volume":"169","author":"Chiosea","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2026.116776_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.109.202028","article-title":"Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline","volume":"30","author":"Caruso","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejca.2026.116776_bib21","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1038\/ncomms6203","article-title":"Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER","volume":"5","author":"van den Beucken","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116776_bib22","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-16-1762","article-title":"Hypoxia causes downregulation of dicer in hepatocellular carcinoma, which is required for upregulation of hypoxia-inducible factor 1alpha and epithelial-mesenchymal transition","volume":"23","author":"Ibrahim","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116776_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI89212","article-title":"HIF-1alpha promotes autophagic proteolysis of Dicer and enhances tumor metastasis","volume":"128","author":"Lai","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2026.116776_bib24","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1038\/onc.2015.492","article-title":"Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression","volume":"35","author":"Rupaimoole","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2026.116776_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41698-024-00585-y","article-title":"Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma","volume":"8","author":"Martin","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally selected rank statistics","volume":"1","author":"Lausen","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.ejca.2026.116776_bib27","doi-asserted-by":"crossref","first-page":"72672","DOI":"10.18632\/oncotarget.12183","article-title":"Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis","volume":"7","author":"Shan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2026.116776_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083724","article-title":"Prognostic significance of deregulated dicer expression in breast cancer","volume":"8","author":"Caffrey","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.ejca.2026.116776_bib29","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","article-title":"Dicer, Drosha, and outcomes in patients with ovarian cancer","volume":"359","author":"Merritt","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2026.116776_bib30","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/0284186X.2022.2089591","article-title":"Hypoxia and local tumour control in squamous cell carcinoma of the anus - a hypothesis-generating study","volume":"61","author":"Lefevre","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1080\/14756366.2020.1772250","article-title":"Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"35","author":"Lorenzo-Pouso","year":"2020","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.ejca.2026.116776_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114096","article-title":"Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.116776_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020375","article-title":"Investigation of the prognostic role of carbonic anhydrase 9 (CAIX) of the cellular mRNA\/protein level or soluble CAIX protein in patients with oral squamous cell carcinoma","volume":"20","author":"Eckert","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2026.116776_bib34","first-page":"995","article-title":"Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells","volume":"24","author":"Rafajova","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2026.116776_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2009.03.004","article-title":"PI3K\/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines","volume":"282","author":"Shafee","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2026.116776_bib36","first-page":"4469","article-title":"Lowered oxygen tension induces expression of the hypoxia marker MN\/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3\u2032-kinase","volume":"62","author":"Kaluz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2026.116776_bib37","doi-asserted-by":"crossref","first-page":"29003","DOI":"10.1074\/jbc.M112.373365","article-title":"Functional importance of Dicer protein in the adaptive cellular response to hypoxia","volume":"287","author":"Ho","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2026.116776_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112413","article-title":"Rapid downregulation of DICER is a hallmark of adipose tissue upon high-fat diet feeding","volume":"595","author":"Madsen","year":"2025","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejca.2026.116776_bib39","first-page":"43","article-title":"RADIANCE - Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial","volume":"23","author":"Martin","year":"2020","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:09:31Z","timestamp":1783123771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S0959804926005575"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116776","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of DICER and CA9 expression in patients with anal squamous cell carcinoma treated with definitive chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116776"}}